They also found different effects of CS cessation on ACPA-positive and -negative cases; the association of CS with RA no longer persisted after 20 years of cessation in ACPA-negative cases, while the association persisted with cumulative dose dependency in ACPA-positive cases. The gene discussed is PRTN3; the disease is rheumatoid arthritis.